Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled inDrosophila melanogaster
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Beneficial effects of increased lysozyme levels in Alzheimer's disease modelled inDrosophila melanogaster
Authors
Keywords
-
Journal
FEBS Journal
Volume 283, Issue 19, Pages 3508-3522
Publisher
Wiley
Online
2016-08-26
DOI
10.1111/febs.13830
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AβPP processing results in greater toxicity per amount of Aβ1-42than individually expressed and secreted Aβ1-42inDrosophila melanogaster
- (2016) Liza Bergkvist et al. Biology Open
- Protective properties of lysozyme on β-amyloid pathology: implications for Alzheimer disease
- (2015) Linda Helmfors et al. NEUROBIOLOGY OF DISEASE
- A Genome-wide Gene-Expression Analysis and Database in Transgenic Mice during Development of Amyloid or Tau Pathology
- (2015) Mar Matarin et al. Cell Reports
- Development and characterization of an aged onset model of Alzheimer's disease in Drosophila melanogaster
- (2014) Siddhita D. Mhatre et al. EXPERIMENTAL NEUROLOGY
- Non-chaperone Proteins Can Inhibit Aggregation and Cytotoxicity of Alzheimer Amyloid β Peptide
- (2014) Jinghui Luo et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Interaction of Amyloid Inhibitor Proteins with Amyloid Beta Peptides: Insight from Molecular Dynamics Simulations
- (2014) Payel Das et al. PLoS One
- Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease
- (2013) Bin Zhang et al. CELL
- Human lysozyme inhibits the in vitro aggregation of Aβ peptides, which in vivo are associated with Alzheimer's disease
- (2013) Jinghui Luo et al. CHEMICAL COMMUNICATIONS
- Lysosomal Network Proteins as Potential Novel CSF Biomarkers for Alzheimer’s Disease
- (2013) Andrea Armstrong et al. NEUROMOLECULAR MEDICINE
- Neuropathological Alterations in Alzheimer Disease
- (2013) A. Serrano-Pozo et al. Cold Spring Harbor Perspectives in Medicine
- Correspondence between in vivo 11C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques
- (2012) Ira Driscoll et al. ACTA NEUROPATHOLOGICA
- Microglia and Inflammation in Alzheimers Disease
- (2012) Shweta Mandrekar-Colucci et al. CNS & Neurological Disorders-Drug Targets
- Curcumin Promotes A-beta Fibrillation and Reduces Neurotoxicity in Transgenic Drosophila
- (2012) Ina Caesar et al. PLoS One
- Small-Animal PET Imaging of Amyloid-Beta Plaques with [11C]PiB and Its Multi-Modal Validation in an APP/PS1 Mouse Model of Alzheimer's Disease
- (2012) André Manook et al. PLoS One
- National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach
- (2011) Thomas J. Montine et al. ACTA NEUROPATHOLOGICA
- Disease-related amyloidogenic variants of human lysozyme trigger the unfolded protein response and disturb eye development in Drosophila melanogaster
- (2011) Janet R. Kumita et al. FASEB JOURNAL
- Detection of early locomotor abnormalities in a Drosophila model of Alzheimer's disease
- (2011) Thomas R. Jahn et al. JOURNAL OF NEUROSCIENCE METHODS
- The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
- (2011) Eric Karran et al. NATURE REVIEWS DRUG DISCOVERY
- Astrocytes: biology and pathology
- (2009) Michael V. Sofroniew et al. ACTA NEUROPATHOLOGICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started